Comparing the oncologic outcomes of breast-conserving surgery for breast cancer patients performed either upfront or following neoadjuvant chemotherapy: a matched retrospective cohort
Breast cancer treated with BCS after NACT has a low incidence of positive margins and similar oncologic outcomes compared to BCS performed upfront.
Authors
- Hazem Assi (ORCID: https://orcid.org/0000-0002-8483-0938)
- Selim G. Gebran (ORCID: https://orcid.org/0000-0001-8481-4201)
- Jaber Abbas (ORCID: https://orcid.org/0000-0002-4606-5796)
- Eman Sbaity (ORCID: https://orcid.org/0000-0003-2969-4782)
- Zeina Hassan
- Bashar Hassan (ORCID: https://orcid.org/0000-0002-4037-8740)
- Malak Ghezzawi (ORCID: https://orcid.org/0009-0009-0702-0139)
- Jacques Azzi (ORCID: https://orcid.org/0000-0002-9862-8669)
- Mayssam Nehme (ORCID: https://orcid.org/0000-0001-9189-6495)
- Ziad Salem
- Hussein Nassar
- Cynthia Alame
Institutions
- American University of Beirut Medical Center (LB)
- American University of Beirut (LB)
Publication Details
- Journal
- Cancer Treatment and Research Communications
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ctarc.2025.100984
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00